image
Healthcare - Biotechnology - NASDAQ - BM
$ 19.81
-0.792 %
$ 1.45 B
Market Cap
-33.42
P/E
Price Target Average
85.76%
Revenue Forecast Estimate
27.77%
EBIT Estimate
3.44%
Net Income Estimate
57.38%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Kiniksa Pharmaceuticals, Ltd.
image
Wall Street analysts predict an average 1-year price target for KNSA of $36.8 , with forecasts ranging from a low of $34 to a high of $40 .
KNSA Lowest Price Target Wall Street Target
34 USD 71.63%
KNSA Average Price Target Wall Street Target
36.8 USD 85.76%
KNSA Highest Price Target Wall Street Target
40 USD 101.92%
Price
Max Price Target
Min Price Target
Average Price Target
404035353030252520201515Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart KNSA

image
$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart KNSA

image
$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)($180.0m)($180.0m)202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart KNSA

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)202120212022202220232023202420242025202520262026202720272028202820292029